Latanoprost Unimed Pharma

Latanoprost, the active ingredient in Latanoprost Unimed Pharma, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It is employed to lower intra‑ocular pressure in patients with primary open‑angle glaucoma or ocular hypertension and is prescribed by eye care specialists to manage chronic eye pressure elevation.

GNH USA supplies Latanoprost Unimed Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Latanoprost is a prostaglandin analog used to treat ocular conditions characterized by elevated intra‑ocular pressure. Primary open-angle glaucoma: reduces intra‑ocular pressure to slow disease progression. Ocular hypertension: lowers eye pressure to prevent conversion to glaucoma. Secondary open-angle glaucoma: helps control pressure when other treatments are insufficient.

Latanoprost may cause ocular and systemic adverse reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Darkening of iris: gradual pigmentation change. - Eye irritation: burning or stinging sensation. - Blurred vision: transient visual disturbance. - Dry eye: reduced tear production.

Serious or Rare Side Effects: - Paradoxical increase in intra‑ocular pressure. - Uveitis: inflammation of the uveal tract. - Corneal edema: swelling of the cornea. - Allergic reaction: contact dermatitis or swelling. - Systemic hypersensitivity: rare anaphylactic response.

When prescribing Latanoprost, clinicians should consider several safety measures. Baseline IOP assessment: measure intra‑ocular pressure before starting therapy. Regular monitoring: schedule periodic IOP checks to evaluate response. Avoid in active ocular inflammation: contraindicated in uveitis. Caution with herpetic eye disease: may reactivate infection. Do not combine with other prostaglandin analogs: risk of additive effects. Store at room temperature: keep in original container, protect from light and moisture.

Latanoprost can interact with other ophthalmic and systemic agents.

Major Interactions (Avoid): - Concomitant use with other prostaglandin analog eye drops: may cause excessive IOP lowering. - Use with ocular prostaglandin F2α analogs: increased risk of side effects.

Moderate Interactions (Monitor Closely): - Topical non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce efficacy. - Systemic carbonic anhydrase inhibitors: additive IOP‑lowering effect. - Topical corticosteroids: may diminish response. - Antihistamine eye drops: possible irritation. - Contact lens wear: may affect drug distribution.